scPharmaceuticals Inc. (SCPH) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts SCPH Hot Sheet
Join SI Premium – FREE
scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q4 EPS of ($0.35), $0.03 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $12.15 million versus the consensus estimate of $12.13 million.
For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Park-Ohio Holdings (PKOH) Tops Q2 EPS by 11c; raises guidance
- Chime Financial, Inc. (CHYM) Tops Q2 EPS by 17c ; Offers Guidance
- Tennant Co. (TNC) Misses Q2 EPS by 53c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
